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The perilymphatic space of the guinea pig cochlea was perfused with various concentrations of Ca*+ , 
Mg=+ and, gentamicin. Cochleae microphonic potentials (CM) were essentially stable when solutions 
contained 1 mM Ca2+ plus 2 mM Mg’+, 1 mM Ca2+ and no Mg2+ or when both Ca2+ and Mg2+ were 
omitted, In the absence of Ca2+, the Presence of 2 mM Mg2+ or 1 mM EGTA markedly decreased CM. 
Addition of 3 mM gentamicin lowered CM, the magnitude of the effect depending on the concentra- 
tion of CaZ+ present. Ten mM Ca ‘+ eliminated the action of the drug. In the absence of Caa+ , the effects 
of Mg2+ and genta~cin were additive. 
When the application of gentamicin was foIlowed by perfusion with drug-free medium, suppression of 
CM by 3 mM drug could be reversed w$h 10 mM Ca2+ but not with 1 mM Ca’+. Loss of CM was 
irreversible when administration of 10 mM Ca*+ 
increased to’ 10 mM. 
was delayed or when the drug concentration was 
The results are consistent with our previous hypothesis of a biphasic mechanism of aminoglycoside 
toxicity: an initial action competitive with calcium ions and reversible and a second step, non-com~titive 
and irreversible. 
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Introduction 
AminogIycoside antibiotics exert three major toxic actions on mammalian tissues: 
block of neuromuscular and ganghonic transmission [ 121, nephrotoxicity [S] and 
otototicity [2]. Each of these effects has its own characteristics and relationships 
between them are not readily apparent. Antagonism by calcium has been reported 
for the actions of aminoglycosides at neuromuscular and synaptic junctions f12,17] 
but not for nephro- and ototoxicity; neuromuscular block and renal damage are 
reversible while cochlear effects are irreversible and may even progress after cessa- 
tion of drug treatment. 
Studies in the lateral line organ, however, suggest that the ototoxic effects of 
aminoglycosides are influenced by cations and may be reversible under specific 
conditions. The suppression of ~cropho~c output by low streptomycin concentra- 
tions was reversed by high (#‘I while high drug concentrations acted irreversibly 
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[19]; the effects of neomycin on afferent synchronization were somewhat mitigated 
by the addition of 20 mM Ca2+ [ 151; and calcium prevented the action of 
dihydrostreptomycin on extracellular receptor potentials and the afferent nerve 
response [7]. 
We have previously proposed a hypothesis of aminoglycoside toxicity based on 
in vivo and in vitro observations. It postulates a biphasic membrane action of the 
drugs [9,18]: aminoglycosides first displace membrane calcium in a step that is 
competitive with calcium and reversible; secondly, they specifically interact with the 
acidic phospholipid, phosphatidylinositol bisphosphate, a process non-competitive 
with Ca” and leading to irreversible membrane damage. While the details of this 
model were delineated primarily from in vitro drug-lipid interactions [9,14] the 
hypothesis suggests a sequence of in vivo actions. The present study tests the 
reversibility and calcium antagonism of gentamicin-induced loss of cochlear micro- 
phonics in perilymphatic perfusions .of the guinea pig cochlea. 
Materials and Methods 
Perilymphatic perfusions were carried out in male albino guinea pigs (200-400 g). 
Surgical and perfusion techniques were essentially as previously described [8,11]. An 
animal with a positive Preyer hearing reflex was anesthetized with pentobarbital(20 
mg/kg body wt., i.p.), atropine sulfate (0.05 mg/kg body wt., s.c.) and Innovar (0.5 
ml/kg body wt., i.m. containing 0.4 mg fentanyl and 20.0 mg droperidol/ml). Body 
temperature was maintained at 37 5 1 ‘C with a heating pad and artificial respiration 
provided through a tracheal cannula. 
Glass capillaries were implanted into the basal turn of Scala tympani and Scala 
vestibuli. Cochlear microphonic potentials (CM) were measured from an electrode in 
one of the capillaries in response to a sound stimulus of white noise, 20-4000 Hz, 
delivered through an earphone. The sound intensity was adjusted to approximately 
70 dB SPL to give an initial CM of 200-400 PV (RMS). Perilymphatic spaces were 
perfused at a rate of approximately 30 pl/min with artificial perilymph containing 
130 mM NaCl, 5 mM KCl, 1 mM CaCl,, 2 mM MgCl,, 0.1 mM NaH,PO,, 10 mM 
NaHCO,, 5 mM glucose and 10 mM Hepes, final pH, 7.4. After CM had stabilized 
for 30 min the ‘control perfusate’ was switched to the ‘experimental perfusate’ 
containing the drug and the perfusion continued. Experiments were usually carried 
out for 90-120 min but perfusions without drugs could be extended for up to 3 h 
without major (c 20%) loss of CM. Animals with an initial CM of less than 200 PV 
or with an unstable CM during the control period (loss of > 10%) were eliminated 
from the study. 
Results are expressed as initial rate of loss of CM (%/mm) as well as the absolute 
loss after 30 min of drug perfusion. These two measurements, while yielding 
essentially similar results, are not identical. The rate of loss, particularly at high drug 
concentrations, is not necessarily linear for 30 min. Input-output functions of CM 
before and after perfusion of gentamicin showed that measurements at the chosen 
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fixed intensity were representative of the drug-induced CM loss. 
Gentamicin sulfate was a gift from the Schering Corp. (Bloomfield, N.J.). 
Results 
Prior to testing the aminoglycoside, the effects of the divalent cations Ca2+ and 
Mg2+ in the artificial perilymph were investigated (Table I). In the presence of both 
1 mM Ca” and 2 mM Mg 2+ CM was essentially stable over the experimental 
period. Neither the omission of ‘Mg2+ nor the simultaneous omission of Ca2+ and 
Mg 2+ had significa nt effects. However, when Ca2+ was absent from the medium, 
the presence of Mg2+ or 1 mM EGTA led to a marked decrease of CM. While the 
actions of Mg2+ and gentamicin (see below) were apparent within a few minutes 
after reaching the cochlea (delay 3-7 min), the onset of EGTA action was highly 
variable (delay 6-52 min). Therefore, the apparent loss at 30 min is not a meaningful 
measure in this case. 
The addition of 3 mM gentamicin to the perfusate lowered CM significantly (Fig. 
1 and Table II). The magnitude of the effect was clearly dependent on the concentra- 
tion of Ca2+ present, being highest in the absence of Ca2+ . 10 mM Ca2’ eliminated 
the action of gentamicin: a short, initial loss of CM did not persist and CM 
recovered to reach essentially control values (Fig. 1). In contrast to the action of 
Ca2+, Mg 2+ did not antagonize the aminoglycoside action. In the absence of 
calcium, effects of Mg2+ and drug were additive. 
TABLE I 
EFFECT OF DIVALENT CATIONS ON COCHLEAR MICROPHONICS 
Perilymphatic perfusions were carried out as described in Materials and Methods. Control perfusate (I 
mM Ca*+, 2 mM Mg++) was perfused during a 30 min period directly preceding the application of the 
experimental perfusate. Rate of loss (%/mm) is initial rate; I CM lost at 30 min refers to time after 
application of experimental medium (see Materials and Methods). Numbers are means *SD., with 










+ 1 mM EGTA 






0.05=0.04 1.02 * 0.62 l 
0.09*0.07 3.57* 1.28 * 
CM lost n 





26*13 * 9 
** 6 
* Differs from control perfusate (paired r-test): P ~0.01. 
** Variable delay of effect (6-52 mm). 
182 
For the study of reversibility of gentamicin-induced loss of CM, the drug was first 
administered with regular artificial perilymph containing 1 mM Ca” and 2 mM 
Mg . 2+ (Fig 2, point A). After an initial controlled loss of CM, drug-containing 
Fig. 1. Time course of gentamicin and calcium action on cochlear microphonic potentials. Perilymphatic 
perfusions were carried out as described in Materials and Methods. Following the control perfusion 
(‘stabilizing period’, O-30 min), the perfusate was changed at point A to experimental perfusate contain- 
ing artificial perilymph with the following variations: =, no additions; -, 3 mM gentamicin; - - -, 3 mM 
gentamicin and 10 mM CaCIa; -.-, 10 mM CaCl,, Note that ‘artificial perilymph’ always contains 1 mM 
CaCl,. Curves show typical experimental results. 
TABLE II 
EFFECT ON GENTAMICIN TOXICITY OF SIMULTANEOUSLY APPLIED Ca2+ AND Mg*’ 
Perilymphatic perfusions Were carried out as described in Materials and Methods. Control perfusate (1 
mM Ca2+, 2 mM Mg2+) was perfused for 30 min preceding the application of the experimental 
perfusate. Rate of loss (%/mm) is initial rate; 46 CM lost at 30 min refers to time after application of 
experimental medium (see Materials and Methods). Numbers are means * S.D., with numbers of animals 
(n f given in last column. 
Concentrations in Loss of CM (%/mm) during CM lost n 
experimental perfusate (mM) at 30 min 
Control Experimental (%) 
Gentamicin Ca2+ Mg2+ perfusion perfusion 
3 1 2 0.08~0.11 0.56-cO.16 * 14r 5’ 7 
3 0 0 0.06 * 0.08 1.2120.62 * 24-11 * 11 
3 10 2 0.07 -co.06 0.58kO.17 * 3% 2 6 
3 I 0 0.08 2 0.07 0.5O-tO.18 * 10-c 6’ 8 
3 0 2 0.05 It: 0.09 2.86-t 1.25 ** 46-cll * 4 
0 10 2 0.05 -c 0.08 0.12-co.20 lk 6 7 
* Differs from control (paired t-test): P cO.01. 
** P =0.02. 
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Fig. 2. Reversibility of genta~cin-induced suppression of cochlear microphonic potentials. Pe~lymphatic 
perfusions were carried out as described in Materials and Methods. Following the control perfusion (O-30 
min), the perfusate was changed a first time at point A to experimental perfusate containing gentamicin, a 
second time at point I3 to wash perfusate without drug; in one series of experiments, a third change was 
made at point C. The variations of artificial perilymph were: -, 3 mM gentamicin at A, 10 mM CaCl, at 
B; -e-, 3 mM gentamicin at A, no additions at B, 10 mM CaCl, at C; - - -, 10 mM gentamicin at A, 10 
mM CaCl, at B. Note that ‘artificial perilymph’ always contains 1 mM CaCl,. Curves show typical 
experimental results. 
TABLE III 
REVERSIBILITY OF LOSS OF COCHLEAR MICROPHONICS 
Cochlear perfusions were carried out as described in Materials and Methods, and Results. Control 
perfusate (1 mM Ca 2+, 2 mM Mg*+ ) was perfused for 30 min. followed by perfusion with experimental 
medium (see also Fig. 2, point A) which was subsequently exchanged for the ‘wash’ perfusate (Fig. 2, point 
8). Rate of loss (%/min) refers to initial rate (see Materials and Methods); minimum of CM refers to the 
minimum of CM during the experiment before reversal of slope. When no minimum was apparent (i.e. no 
recovery under the conditions 3 mM Gm/l mM Cazf or 10 mM Gm) the value refers to CM at the 
change of slope induced by the wash. Numbers are means * S.D., with number of animals given (n) in 
the last column. 
Additions to [Ca2+ ] in Loss of CM (W/min) during Minimum CM after n 
experimental wash of CM 1 hr wash 
perfusate (mM) perfusate Control Experimental (% of (W of control) 
(mM) perfusion perfusion control) 
Gm, 3 1 0.10~0.05 1.0220.33 l 75-c 5 7l-cl7 5 
None 10 0.0s * 0.03 0.09-t0.10 98k 1 101-t 9 5 
Gm, 3 10 0.11’0.05 0.92*0.18 * 802 3 104= 4,” 5 
Gm, 10 10 0.06-to.03 4.20* 1.27 * 602 10 58-t 18 4 
Mg 2+, 10 10 0.09 5 0.05 14620.57 * 72-c 3 86*16*** 7 
EGTA, 1 10 0.07 2 0.07 1.31-co.43 * 812 6 90-c 10 ** 7 
l Differs from control (paired r-test): P <O.Ol. 
** Differs from ~nimum CM: P (0.01. 
*** Differs from minimum CM: P ~0.035. 
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‘experimental perfusate’ was exchanged for a drug-free ‘wash perfusate’ with varying 
calcium concentrations (Fig. 2, point B). When gentamicin was administered at 3 
mM, followed by wash perfusate with 1 mM Ca2+, loss of CM continued after 
elimination of the drug from the cochlea, albeit a change to a lesser loss per min 
after 5 min (Fig. 2, Table III); final subsequent perfusion with 10 mM Ca2+ in 
perilymph (Fig. 2, point C) did not recover CM. In contrast, when 10 mM Ca2’ was 
perfused immediately following 3 mM gentamicin (Fig. 2, point B) CM recovered to 
control values within about 40 min. Such reversibility by 10 mM Ca2+ was not 
observed when the initial drug concentration was raised to 10 mM gentamicin. The 
detrimental effects of 10 mM Mg2+ or 1 mM EGTA on CM could be reversed, at 
least partially, by 10 mM Ca2+ (TableIII). 
The cochlear microphonic potential is a sensitive indicator of noxious influences 
on the cochlea including damage by aminoglycosides [3]. While the origins and 
functions of this a.c. potential remain obscure, it is well characterized in its 
dependence on the ionic milieu of the inner ear fluids. The requirement for calcium 
ions [6] is supported in this study and it is evident that the endogenous pool of 
calcium is under strict homeostatic control. Excess Ca2+ in perilymphatic perfusions 
raises CM [lo] while endolymphatic application lowers CM [ 161. The endogenous 
Ca2+ is also not easily exchangeable. The absence of calcium from the perfusion 
medium does not adversely affect CM unless magnesium ion or the calcium chelator 
EGTA are present. Magnesium appears to act in a competitive manner as the ratio 
of Ca2’ :Mg2+ determines the effect on the CM. This is in good agreement with 
studies on the lateral line organ of the mudpuppy [ 131. Furthermore, CM depressed 
by magnesium recovers with subsequent _administration ‘of calcium indicating the 
reversibility of its action. 
Calcium antagonism and reversibility of aminoglycoside ototoxicity, on the other 
hand, appear to be complex phenomena. Wersiill and Flock [19] reported that in the 
lateral line organ, high K+ reversed the effect of streptomycin on the microphonic 
output, provided the drug concentrations remained low. Shiozawa [ 151 found simul- 
taneous administration of Ca2+ rather than Kf effective in restoring adverse 
neomycin effects. In contrast to the results from the lateral line organ, aminoglyco- 
side actions in the mammalian ear are generally considered irreversible. 
The complexity of the problem and a possible explanation for the apparently 
discrepant behavior of the lateral line and cochlea can be seen in our studies. 
Calcium antagonism and reversibility of ototoxicity are limited to a narrow range of 
conditions with regard to both concentration and duration of drug exposure. 
It is evident that effects caused by low concentrations of gentamicin and short 
treatment are readily antagonized by Ca 2+ This is first apparent in the simulta- . 
neous application of Ca2+ to the perfusate containing 3 mM gentamicin. The 
calcium-dependent restoration of CM is consistent with a competitive action of the 
two compounds which we previously observed in natural and artificial membranes 
[9,14,18]. 
Secondly, a perfusion with 10 mM Ca2+ is effective in restoring CM if directly 
applied after exposure of the cochlea to 3 mM gentamicin. However, after longer 
exposures or higher concentrations of the drug, reversibility can no longer be 
observed. High calcium (10 mM) failed to reverse the drug effect when its applica- 
tion was delayed by 60 min, although the cochlea was washed free of excess drug 
during this time by artificial perilymph containing 1 mM Ca’+. Similarly, calcium 
antagonism is no longer observed when gentamicin is raised to 10 mM. 
Our demonstration of the biphasic ototoxic action of gentamicin has both 
theoretical and clinical implications. It is clearly consistent with and supports our 
previous hypothesis of a two-step or biphasic action of aminoglycosides. The initial 
displacement of calcium and concomitant inhibition of membrane function are 
reversible. The second step, postulated to be a specific interaction with a receptor 
like phosphatidylinositol bisphosphate, is non-competitive with Ca2+ and essentially 
irreversible [ 141. 
Of potential clinical importance is the observation that aminoglycoside ototoxi- 
city is initially reversible. In practice, however, means to manipulate calcium levels 
in the inner ear are limited. Juhn reported [4] only transiently increased per- 
ilymphatic Ca2+ following hyp ercalcemia induced by CaCl, injections in chinchillas. 
Generally, cochlear calcium concentrations follow serum concentrations which are 
under homeostatic control. Increased calcium loads are efficiently excreted by the 
kidney. Also, it has to be considered that an antagonism by calcium will not only be 
directed against the toxic effects of aminoglycosides but also against their anti- 
bacterial efficacy [I]. 
Drug concentrations in these model studies are higher than those expected in the 
cochlea after application of clinically relevant doses (0.01-0.1 mM, Tran Ba Huy 
and Schacht, in preparation). The fact that 1 mM Ca2+, the approximate concentra- 
tion in serum and perilymph, is rather ineffective in suppressing aminoglycoside 
damage in perfusions should therefore not lead to false conclusions. Physiological 
concentrations of calcium may well be effective antagonists of aminoglycosides in 
vivo until time of exposure or concentration of drug reach a certain limit. It would 
be of interest to determine this limit in viva. 
In summary, our study shows that initial gentamicin actions on the guinea pig 
cochlea are reversible by calcium, similarly to those at the neuromuscular junction 
and kidney.’ Depending on duration and concentration of the drug, irreversible 
damage will follow in the cochlea. 
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